Scope Fluidics S.A. (WSE:SCP)
Poland
· Delayed Price · Currency is PLN 138.20
-0.60 (-0.43%)
Apr 29, 2026, 2:17 PM CET
Scope Fluidics Revenue
In the year 2025, Scope Fluidics had annual revenue of 100.00K PLN, down -23.66%. Scope Fluidics had revenue of -598.00K in the quarter ending December 31, 2025, a decrease of -3,090.00%.
Revenue
100.00K
Revenue Growth
-23.66%
P/S Ratio
4,397.56
Revenue / Employee
757.58
Employees
132
Market Cap
439.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.00K | -31.00K | -23.66% |
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.41B |
| NEUCA | 13.64B |
| Synektik Spólka Akcyjna | 706.45M |
| Celon Pharma | 225.60M |
| Selvita | 371.13M |
| Ryvu Therapeutics | 87.70M |
| Centrum Medyczne ENEL-MED | 820.59M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |